Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

TCR peptide vaccine induces immune response in MS

June 30, 1997

Atypical antipsychotic from Taisho/Nihon Nohyaku characterized in rats

June 30, 1997

Synthelabo reveals 5-HT4/5-HT3 receptor ligands

June 30, 1997

Cambridge NeuroScience suspends phase III trial of Cerestat following interim data analysis

June 27, 1997

BMS to comarket antiemetic azasetron in Japan

June 27, 1997

NDA for entacapone scheduled for submission this month

June 27, 1997

Preclinical profile of MDL-27192

June 27, 1997

SKB discovers first selective human 5-HT1B receptor ligand

June 27, 1997

Novel anxiolytic and antidepressant buspirone analogue characterized

June 27, 1997

MS&D reports another series of potent and selective 5-HT1D agonists

June 27, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Atai Therapeutics patents new 5-HT2 receptor agonists
BioWorld Science
Atai Therapeutics Inc. has identified new 5-HT2 receptor agonists potentially useful for the treatment of psychiatric disorders.